Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Immunogenicity and Safety of Liquid Bivalent Oral Poliomyelitis Vaccine: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety of Liquid Bivalent Oral Poliomyelitis Vaccine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02434770).
- Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Immunogenicity and Safety Study of 1 and 2 Doses of GlaxoSmithKline (GSK) Biologicals’ Meningococcal Vaccine MenACWY-TT (GSK134612) in Toddlers, Persistence up to 5 Years After Vaccination and Co-administration With Pfizer’s Prevenar 13™Vaccine: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety Study of 1 and 2 Doses of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine MenACWY-TT (GSK134612) in Toddlers, Persistence up to 5 Years After Vaccination and Co-administration…
- Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study.: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study.: primary endpoint results, effect…
- Immunogenicity and Safety Study of Booster Dose of GSK Biologicals’ IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older: primary endpoint results, effect estimate…
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals’ Meningococcal Conjugate Vaccine (GSK134612) When Co-administered With Boostrix® in Subjects Between 11 and 25 Years of Age: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Conjugate Vaccine (GSK134612) When Co-administered With Boostrix® in Subjects Between 11 and 25 Years of Age: primary endpoint results,…
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals’ Meningococcal Vaccine With or Without Co-administration of Cervarix and Boostrix in Female Adolescents and Young Adults: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine With or Without Co-administration of Cervarix and Boostrix in Female Adolescents and Young Adults: primary endpoint results, effect…
- Immunogenicity and Safety Study of GSK Biologicals’ Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF)…
- Immunogenicity and Safety Study of GSK Biologicals’ Meningococcal Vaccine GSK 134612 Versus Menactra® in Healthy Adolescents/Adults: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine GSK 134612 Versus Menactra® in Healthy Adolescents/Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Different Suppliers: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Different Suppliers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Immunogenicity of GSK Biologicals’ Pandemic Influenza Vaccine (GSK1562902A) at Different Boosting Vaccination Schedules: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity of GSK Biologicals' Pandemic Influenza Vaccine (GSK1562902A) at Different Boosting Vaccination Schedules: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Immunogenicity of Metreleptin in Patients With Generalized Lipodystrophy: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity of Metreleptin in Patients With Generalized Lipodystrophy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04026178).
- Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Immunogenicity, Safety, Reactogenicity and Persistence of an Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity, Safety, Reactogenicity and Persistence of an Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above: primary endpoint results, effect estimate with confidence interval,…
- Immunohistochemical Evaluation of Protein P16 Expression in Ovarian Germ Cell Tumors.: Complete Statistical AnalysisIndependent statistical analysis of Immunohistochemical Evaluation of Protein P16 Expression in Ovarian Germ Cell Tumors.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Immunologic Determinants of Response to Pembrolizumab (MK-3475) in Advanced Melanoma (MK-3475-161/KEYNOTE-161): Complete Statistical AnalysisIndependent statistical analysis of Immunologic Determinants of Response to Pembrolizumab (MK-3475) in Advanced Melanoma (MK-3475-161/KEYNOTE-161): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Immunomodulatory Properties of Ketamine in Sepsis: Complete Statistical AnalysisIndependent statistical analysis of Immunomodulatory Properties of Ketamine in Sepsis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01089361).
- Immunophenotyping of Peripheral T Cells After T Cell Depletion With Alemtuzumab: Complete Statistical AnalysisIndependent statistical analysis of Immunophenotyping of Peripheral T Cells After T Cell Depletion With Alemtuzumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Immunotherapy Study for Patients With Stage IV Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Immunotherapy Study for Patients With Stage IV Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02054520).
- Immunotherapy With APC8015 (Sipuleucel-T, Provenge) for Asymptomatic, Metastatic, Hormone-Refractory Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Immunotherapy With APC8015 (Sipuleucel-T, Provenge) for Asymptomatic, Metastatic, Hormone-Refractory Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Immunotherapy With BCMA CAR-T Cells in Treating Patients With BCMA Positive Relapsed or Refractory Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Immunotherapy With BCMA CAR-T Cells in Treating Patients With BCMA Positive Relapsed or Refractory Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions: Complete Statistical AnalysisIndependent statistical analysis of Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Immunotherapy With or Without Radiation Therapy for Metastatic Urothelial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Immunotherapy With or Without Radiation Therapy for Metastatic Urothelial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04936230).
- IMOVAIndependent statistical analysis of Evaluation of Response to the Neoadjuvant Chemotherapy for Advanced Ovarian Cancer by Multimodal Functional Imaging: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- IMPACTIndependent statistical analysis of An Evaluation of Novel Glucose Sensing Technology on Hypoglycaemia in Type 1 Diabetes (IMPACT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- IMPACTIndependent statistical analysis of Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- IMPACTIndependent statistical analysis of Improving Patient Outcomes by Selective Implantation of the Zephyr EBV - Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Impact of Anesthetic Choice (Sevoflurane Versus Desflurane) on Airway Reflex Recovery in the Context of Antagonized Neuromuscular Block: Complete Statistical AnalysisIndependent statistical analysis of Impact of Anesthetic Choice (Sevoflurane Versus Desflurane) on Airway Reflex Recovery in the Context of Antagonized Neuromuscular Block: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Impact of Bosutinib on Safety, Tolerability, Biomarkers and Clinical Outcomes in Dementia With Lewy Bodies: Complete Statistical AnalysisIndependent statistical analysis of Impact of Bosutinib on Safety, Tolerability, Biomarkers and Clinical Outcomes in Dementia With Lewy Bodies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Impact of Cannabis on Pain and Inflammation Among Patients With Rheumatoid or Psoriatic Arthritis: Complete Statistical AnalysisIndependent statistical analysis of Impact of Cannabis on Pain and Inflammation Among Patients With Rheumatoid or Psoriatic Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Impact of Chronic Kidney Disease on the Effects of Ticagrelor in Patients With Diabetes and Coronary Artery Disease: Complete Statistical AnalysisIndependent statistical analysis of Impact of Chronic Kidney Disease on the Effects of Ticagrelor in Patients With Diabetes and Coronary Artery Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Impact of COVID-19 on Marshallese Communities in the U.S.: Complete Statistical AnalysisIndependent statistical analysis of Impact of COVID-19 on Marshallese Communities in the U.S.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04474496).
- Impact of E-cigarette Characteristics on Reinforcement and Tobacco Use Patterns: Complete Statistical AnalysisIndependent statistical analysis of Impact of E-cigarette Characteristics on Reinforcement and Tobacco Use Patterns: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03844672).
- Impact of E-cigarette Device Warnings: Complete Statistical AnalysisIndependent statistical analysis of Impact of E-cigarette Device Warnings: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05714982).
- Impact of Emergency Department Probiotic (LGG) Treatment of Pediatric Gastroenteritis: Complete Statistical AnalysisIndependent statistical analysis of Impact of Emergency Department Probiotic (LGG) Treatment of Pediatric Gastroenteritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01773967).
- Impact of Family History and Decision Support on High-risk Cancer Screening: Complete Statistical AnalysisIndependent statistical analysis of Impact of Family History and Decision Support on High-risk Cancer Screening: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Impact of Fructose on Metabolism, Energy Homeostasis and Magnetic Resonance Biomarkers in Nonalcoholic Fatty Liver Disease: Complete Statistical AnalysisIndependent statistical analysis of Impact of Fructose on Metabolism, Energy Homeostasis and Magnetic Resonance Biomarkers in Nonalcoholic Fatty Liver Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors: Complete Statistical AnalysisIndependent statistical analysis of Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Impact of Helmet Use in Preschool Children: Complete Statistical AnalysisIndependent statistical analysis of Impact of Helmet Use in Preschool Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01054846).
- Impact of Liraglutide 3.0 on Body Fat Distribution: Complete Statistical AnalysisIndependent statistical analysis of Impact of Liraglutide 3.0 on Body Fat Distribution: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03038620).
- Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics in Healthy Women: Complete Statistical AnalysisIndependent statistical analysis of Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics in Healthy Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00869960).
- Impact of Oral Nutritional Supplements on Patients Undergoing Haematopoietic Stem Cell Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Impact of Oral Nutritional Supplements on Patients Undergoing Haematopoietic Stem Cell Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Impact of Oxytocin on Obstructive Sleep Apnea Induced Changes in Sleep: Complete Statistical AnalysisIndependent statistical analysis of Impact of Oxytocin on Obstructive Sleep Apnea Induced Changes in Sleep: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Impact of Prevnar 13 on Ear Infections in Children: Complete Statistical AnalysisIndependent statistical analysis of Impact of Prevnar 13 on Ear Infections in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01272999).
- Impact of Respiratory Training in Lymphoma Survivors: Complete Statistical AnalysisIndependent statistical analysis of Impact of Respiratory Training in Lymphoma Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05938127).
- Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery: Complete Statistical AnalysisIndependent statistical analysis of Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02352103).